Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Straus

Showing results (141-150 of 215) with videos related to

Pageof 22
Sort By:
Clinical Immunology and Immunopathology|August 1, 1980
Concanavalin A-induced suppressor cell activity in Hodgkin's diseaseR S Schulof, B J Lee, M J Lacher, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1990
Prognostic factors among 185 adults with newly diagnosed advanced Hodgkin's disease treated with alternating potentially noncross-resistant chemotherapy and intermediate-dose radiation therapyD J Straus, J J Gaynor, J Myers, et al.
Investigational New Drugs|May 1, 1991
Mitoxantrone, etoposide, mitoguazone and vinblastine chemotherapy (MV2) in relapsed and refractory lymphomasJ P Crown, S Gulati, D J Straus, et al.
The American Journal of Medicine|March 1, 1991
Small non-cleaved-cell lymphoma (undifferentiated lymphoma, Burkitt's type) in American adults: results with treatment designed for acute lymphoblastic leukemiaD J Straus, G Y Wong, J Liu, et al.
Blood|August 19, 2004
Results of a prospective randomized clinical trial of doxorubicin, bleomycin, vinblastine, and dacarbazine (ABVD) followed by radiation therapy (RT) versus ABVD alone for stages I, II, and IIIA nonbulky Hodgkin diseaseDavid J Straus, Carol S Portlock, Jing Qin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1990
Treatment results with an aggressive chemotherapeutic regimen (MACOP-B) for intermediate- and some high-grade non-Hodgkin's lymphomasA M Schneider, D J Straus, A E Schluger, et al.
The American Journal of Medicine|June 1, 1986
Treatment of stages I and II Hodgkin's disease with three different therapeutic modalitiesB Koziner, J Myers, C Cirrincione, et al.
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|January 1, 1989
Results and prognostic factors following optimal treatment of advanced Hodgkin's diseaseD J Straus, J Gaynor, J Myers, et al.
British Journal of Clinical Pharmacology|April 20, 2011
Additional safety risk to exceptionally approved drugs in Europe?Arna H Arnardottir, Flora M Haaijer-Ruskamp, Sabine M J Straus, et al.
Cancer|January 15, 1988
Primary lymphoma of the liverJ Ryan, D J Straus, C Lange, et al.
Pageof 22

Showing results (141-150 of 215) with videos related to

Sort By:
Pageof 22
Clinical Immunology and Immunopathology|August 1, 1980
Concanavalin A-induced suppressor cell activity in Hodgkin's diseaseR S Schulof, B J Lee, M J Lacher, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1990
Prognostic factors among 185 adults with newly diagnosed advanced Hodgkin's disease treated with alternating potentially noncross-resistant chemotherapy and intermediate-dose radiation therapyD J Straus, J J Gaynor, J Myers, et al.
Investigational New Drugs|May 1, 1991
Mitoxantrone, etoposide, mitoguazone and vinblastine chemotherapy (MV2) in relapsed and refractory lymphomasJ P Crown, S Gulati, D J Straus, et al.
The American Journal of Medicine|March 1, 1991
Small non-cleaved-cell lymphoma (undifferentiated lymphoma, Burkitt's type) in American adults: results with treatment designed for acute lymphoblastic leukemiaD J Straus, G Y Wong, J Liu, et al.
Blood|August 19, 2004
Results of a prospective randomized clinical trial of doxorubicin, bleomycin, vinblastine, and dacarbazine (ABVD) followed by radiation therapy (RT) versus ABVD alone for stages I, II, and IIIA nonbulky Hodgkin diseaseDavid J Straus, Carol S Portlock, Jing Qin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1990
Treatment results with an aggressive chemotherapeutic regimen (MACOP-B) for intermediate- and some high-grade non-Hodgkin's lymphomasA M Schneider, D J Straus, A E Schluger, et al.
The American Journal of Medicine|June 1, 1986
Treatment of stages I and II Hodgkin's disease with three different therapeutic modalitiesB Koziner, J Myers, C Cirrincione, et al.
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|January 1, 1989
Results and prognostic factors following optimal treatment of advanced Hodgkin's diseaseD J Straus, J Gaynor, J Myers, et al.
British Journal of Clinical Pharmacology|April 20, 2011
Additional safety risk to exceptionally approved drugs in Europe?Arna H Arnardottir, Flora M Haaijer-Ruskamp, Sabine M J Straus, et al.
Cancer|January 15, 1988
Primary lymphoma of the liverJ Ryan, D J Straus, C Lange, et al.
Pageof 22